Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00177086 · ClinicalTrials.gov registry record · Phase 3
Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi
A Phase 3 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 3
- Development phase
- 76
- Enrollment target
NCT00177086 is a Phase 3 study that has completed, run by University of Minnesota. The registered enrollment target is 76 participants.
The verdict
NCT00177086, a Phase 3 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 76 participants
- Enrollment target
Study Summary
This study will assess improvement in the percentage of spontaneous stone passage for distal ureteral calculi for alfuzosin compared to placebo, decrease of pain and narcotic/analgesic use associated with stone passage, decrease of the time to spontaneous stone passage, shift in the size distribution of stones passed towards larger sizes.
Interventions
- OTHER Alfuzosin Hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00177086
The ClinicalTrials.gov registry entry for NCT00177086 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alfuzosin Hydrochloride is the first listed.
NCT00177086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00177086 about?
NCT00177086 is a clinical study titled "Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi". This study will assess improvement in the percentage of spontaneous stone passage for distal ureteral calculi for alfuzosin compared to placebo, decrease of pain and narcotic/analgesic use associated with stone passage, decrease of the time to spontaneous stone passage, shift in the size distributio...
What is the current status of trial NCT00177086?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 76 participants. The study started on 2005-09. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00177086?
The interventions under investigation include: Alfuzosin Hydrochloride (OTHER).
Who is sponsoring clinical trial NCT00177086?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.